Dupilumab (Dupixent, Sanofi and Regeneron) significantly reduced exacerbations compared with placebo in children ages 6-11 years who had moderate-to-severe asthma
Continue reading »![](https://mypharmacynews.com/wp-content/uploads/sites/11/2021/07/Dupilumab-Safe-Effective-in-Kids-With-Moderate-to-Severe-Asthma.jpg)
mypharmacynews.com
Home »
Dupilumab (Dupixent, Sanofi and Regeneron) significantly reduced exacerbations compared with placebo in children ages 6-11 years who had moderate-to-severe asthma
Continue reading »Humans are exposed to a variety of toxins and chemicals every day. According to the epithelial barrier hypothesis, exposure to
Continue reading »Thought LeadersDr. Samantha WalkerDirector of Research & InnovationAsthma UK and the British Lung Foundation In light of World Asthma Day,
Continue reading »An overgrowth of yeast in the gut within the first few months of life may cause changes to the immune
Continue reading »The Centers for Disease Control and Prevention (CDC) on Thursday declared racism a serious public health threat and outlined steps
Continue reading »Fewer patients with severe attacks were seen by their GP or admitted to hospital during the COVID-19 pandemic, and fewer
Continue reading »Hawaii, Florida, Seattle and the South of France are on the minds of New York City college students. Those are
Continue reading »NEW YORK (Reuters Health) – Peanut allergy has dropped in Australia after children began to be introduced to peanuts early
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BRICANYL® INJECTION terbutaline sulfate Consumer Medicine Information
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VENTOLIN® INJECTION Salbutamol sulfate Consumer Medicine Information
Continue reading »